Maurice Hinchey on Drugs Dem./Ind./Lib./Working-Fam. Representative (NY-22)

Voted YES on more funding for Mexico to fight drugs.

Provide assistance for Mexico for:
1. counternarcotics and countertrafficking;
2. port & airport security to assist in controlling the Mexico-US and Mexico-Central America borders;
3. intelligence gathering operational technology; and
4. public security and law enforcement, including assistance to the National Council Against Addiction (CONADIC).

Proponent's argument to vote Yes:Rep. HOWARD BERMAN (D, CA-28): The drug crisis facing the US remains a top national security threat. This bill represents a new partnership with Mexico and Central American countries to face the immediate security threat of drug gangs, and help these neighbors build the capacity of their law enforcement agencies.

Opponent's argument to vote No:Rep. MICHAEL McCAUL (R, TX-10): We need a strategy on this side of the border: a two-pronged Approach; a comprehensive strategy that deals not only with the Mexican side but with the US side. And for too long, our border sheriffs and our Border Patrol agents have been outmanned and outgunned. And if we are going to provide assistance to Mexico, it seems to me we ought to be providing assistance to our men and women on our side fighting this war every day.

Rep. TED POE (R, TX-2): I am concerned about drugs and violence on the border, but I am also concerned about corruption. In order to gain control of access corridors in the US, drug cartels are hiring hit men from an elite force in Mexico's military. This group is known as the "Zetas." Some of the Zetas are military deserters that may have been trained in the US. $1 billion in this bill would go to Mexico. And Mexico in its arrogance objects to any conditions we want to put on this money. The administration can offer us no assurance that our equipment and training won't be used against us and neither can Mexico.

Voted NO on military border patrols to battle drugs & terrorism.

Voted NO on prohibiting needle exchange & medical marijuana in DC.

Voted NO on subjecting federal employees to random drug tests.

Legalize medical marijuana.

Title: To provide for the medical use of marijuana in accordance with the laws of the various States. Summary: Transfers marijuana from schedule I of the Controlled Substances Act to schedule II of such Act. Declares that, in a State in which marijuana may be prescribed or recommended by a physician for medical use under applicable State law, no provision of the Controlled Substances Act shall prohibit or otherwise restrict:
• the prescription or recommendation of marijuana by a physician for medical use;

• an individual from obtaining and using marijuana from a physician's prescription or recommendation of marijuana for medical use; or

• a pharmacy from obtaining and holding marijuana for the prescription or recommendation of marijuana by a physician for medical use under applicable State law.

• Prohibits any provision of the Federal Food, Drug, and Cosmetic Act from prohibiting or restricting a State entity from producing or distributing marijuana for the purpose of its distribution for prescription or recommendation by a physician in a State in which marijuana may be prescribed by a physician for medical use.

Rated A by VOTE-HEMP, indicating a pro-hemp voting record.

VOTE HEMP is a non-profit organization dedicated to the acceptance of and free market for Industrial Hemp. Industrial Hemp is non-psychoactive low THC varieties of the cannabis sativa plant. Currently, it is illegal for U.S. farmers to grow Industrial Hemp because it is improperly classified as a "drug" under the Controlled Substances Act. Since changes in law require shifts in thinking and this requires education in the facts, our primary goal is the education of legislators and regulators, farmers and businesses, students and other concerned citizens.

Rated +20 by NORML, indicating a pro-drug-reform stance.

OnTheIssues.org interprets the 2006 NORML scores as follows:

• -30 to -10: "hard-on-drugs" stance (approx. 228 members)
• -9 to +9: mixed record on drug reform (approx. 37 members)
• +10 to +30: pro-drug-reform stance (approx. 109 members)

National Organization for the Reform of Marijuana Law's mission is to move public opinion sufficiently to achieve the repeal of marijuana prohibition so that the responsible use of cannabis by adults is no longer subject to penalty.

NORML is a nonprofit, public-interest lobby that for more than 30 years has provided a voice for those Americans who oppose marijuana prohibition. We represent the interests of the tens of millions of Americans who smoke marijuana responsibly and believe the recreational and medicinal use of marijuana should no longer be a crime.

NORML supports the removal of all criminal penalties for the private possession & responsible use of marijuana by adults, including the cultivation for personal use, and the casual nonprofit transfers of small amounts. This model is called "decriminalization."

NORML additionally supports the development of a legally controlled market for marijuana, where consumers could purchase it from a safe, legal and regulated source. This model is referred to as "legalization."

NORML believes that marijuana smoking is not for kids and should only be used responsibly by adults. As with alcohol consumption, it must never be an excuse for misconduct or other bad behavior. Driving or operating heavy equipment while impaired from marijuana should be prohibited.

NORML strongly supports the right of patients to use marijuana as a medicine when their physician recommends it to relieve pain and suffering.

Lastly, NORML supports the right of farmers to commercially cultivate hemp for industrial purposes, such as food and fiber production.

Allow rehabilitated drug convicts get student loans.

This bill amends the Higher Education Act of 1965 to repeal the provisions prohibiting persons convicted of drug offenses from receiving student financial assistance.

Distribute sterile syringes to reduce AIDS and hepatitis.

To permit the use of Federal funds for syringe exchange programs for purposes of reducing the transmission of bloodborne pathogens, including HIV and viral hepatitis.

Congress finds as follows:
1. Each year, approximately 12,000 Americans contract HIV/AIDS and approximately 19,000 Americans contract the hepatitis C virus directly or indirectly from sharing contaminated syringes.
2. A 2005 comprehensive international review of the evidence of the effectiveness of syringe exchange programs in preventing HIV transmission shows that such programs reduce HIV transmission and are cost-effective.
3. Research has shown that injection drug users who are referred to addiction treatment from syringe exchange programs are more likely to enter and remain in treatment.
4. Research has shown that, by providing safe disposal of used injection equipment, syringe exchange programs significantly reduce the number of improperly discarded syringes in the community, thereby reducing the exposure of police and others to dangers of blood-borne disease from accidental syringe sticks.
5. Syringe exchange programs reduce the prevalence of HIV among injection drug users.
6. Despite the scientific and public health consensus that syringe exchange programs reduce HIV and do not increase substance abuse, a ban on funding syringe exchange has been enacted as part of each Appropriations Act since 1998.
7. The Public Health Service Act, as added by the Ryan White Comprehensive AIDS Resources Emergency Act of 1990, is subject to a statutory ban on funding needle exchange programs.

Let states legalize industrial hemp.

Amends the Controlled Substances Act to exclude industrial hemp from the definition of "marihuana." Defines "industrial hemp" to mean the plant Cannabis sativa L. and any part of such plant, whether growing or not, with a delta-nine tetrahydrocannabinol concentration that does not exceed 0.3% on a dry weight basis. Grants a state regulating the growing and processing of industrial hemp exclusive authority, in any criminal or civil action or administrative proceeding, to determine whether any such plant meets that concentration limit.